TuHURA Biosciences, Inc./NV, 2025-11-10
An SEC Form D private-offering notice from Tampa, FL, a $3,000,000 filer-stated offering target in Biotech. Filed 2025-11-10. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Phase 3 clinical stage immuno oncology company developing therapies to overcome resistance to cancer immunotherapy, including checkpoint inhibitor combination treatments.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Deinde Medical Corp., 2025-11-12, $2M, Miramar, FL
- BioLoomics, Inc., 2025-11-10, $2M, Boulder, CO
- Standard Dental Labs Inc., 2025-11-12, $750K, Orlando, FL
- EPALEX Corp, 2025-11-10, $3.2M, Mountain View, CA
- Metallomix, Inc, 2025-11-10, $10M, Miami, FL
- ARTELO BIOSCIENCES, INC., 2025-11-10, $3.7M, Solana Beach, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.